Top Tweets for #indegene
MOFSL upgrades Indegene to BUY with a ₹708 Target Price, citing outsourcing growth, GenAI adoption and improving margins
#Indegene #MOFSL #StockMarket
Indegene’s Growth Story: Global Expansion, AI & The Future Of Healthcare Tech
Watch LIVE: https://t.co/jNmtWadewZ | #BusinessToday #Indegene #BusinessOutlook #HealthcareTechnology #AIInHealthcare
@shail_bhatnagar | @neetu_csharma | @indegeneinsight https://t.co/7r33zvtYDJ
#INDEGENE – Positive Update ✅
Yesterday stock touched fresh 52wk high.💥
One possible reason behind the recent strength in the stock:
Indegene's US subsidiary was facing a class-action lawsuit.
✓ US Court has now given preliminary approval for the proposed settlement.
✓ Maximum settlement fund is capped at ~$4.72 million.
✓ Actual cash outflow could be much lower, as payment depends on valid claims received.
✓ Company is not required to deposit the entire $4.72 million upfront.
Simply put — a long-pending legal uncertainty is moving closer towards resolution, which is positive for sentiment. ✅
Note: Final court approval is still pending and the hearing is scheduled for January 12, 2027.
Not a buy/sell call. DYOR
#Indegene Ltd
Follow me for more charts
#StockMarket #sharemarket #BREAKOUTSTOCKS #StocksToBuy #stockmarketindia #Nifty50 #Banknifty #Sensex #Optionselling #FnO #optiontrading
Video compilation of charts shared on August 31st 2026.
Standard Format: https://t.co/odV6tbvUgl
Shorts Format: https://t.co/9MKocVpHMx
#indegene #bodalchem #ratnaveer
#INDEGENE It has chopped sideways since the breakout but it is still in play.
THIS IS NOT A BUY/SELL/HOLD RECOMMENDATION. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE MAKING A DECISION.
#swingtrading #indgn
#INDEGENE Come on bulls don't be shy. Let's give it a nice push towards the wave (3) top.
THIS IS NOT A BUY/SELL/HOLD RECOMMENDATION. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE MAKING A DECISION.
#swingtrading #indgn
Stock 5: Indegene Ltd (#INDEGENE)
Stock has broken out of a descending wedge pattern and is been creating a base on daily time frame.
If it closes above 580 on daily basis we can see levels of 620 ( which is around 6%)
This a short term trade purely based on charts.
I spent some time searching and analysing some quality setups they are mostly based on technical charts rather than fundamentals.
But I still have a bearish view on the market ( mentioned about the head and shoulder formation on daily time frame in Nifty) also I have been seeing a lot of IPOs coming up and everyone from everywhere is applying with full force some are even pooling funds to apply for SMEs along with this when everyone is taking about the markets I tend to get careful as all of this is early sign of euphoria and over optimism, which generally leads to a fall in market.
Also Crude is stuck in a symmetric triangle pattern and I am having a feeling that there will be a breakout in that , expecting to see 100-110 levels based on charts, though it means a bearish phase for overall markets. So I am monitoring that closely.
Also DXY just formed a Tweezer bottom so we can see levels of 100 - 100.5 - 101 in coming weeks ( untill some news comes in and changes the structure completely) also it means we can see some pull back in Gold and Silver.
This week if I enter any positions it will be with half the position sizing and with stricter SLs. Expecting a volatile week also rebalancing is also there on Monday.
Mostly I will be sitting on sidelines this week.
#HDFCBANK #Nifty #NSE #JIO #Stocks #StockMarket
Full analysis — the Goldman signal, chart breakout & H2 FY27 growth catalyst 👇
https://t.co/TNtQQnxokR
#Indegene #AI #PharmaTech #StockMarket
Life-sciences company Indegene is scouting acquisitions in clinical research to expand its footprint across the pharmaceutical value chain.
Details by @sohinidastweets 👇
https://t.co/E7IVxF0xA3
#PharmaSector #Indegene #Company
#INDEGENE Come on bulls don't be shy. Let's give it a nice push towards the wave (3) top.
THIS IS NOT A BUY/SELL/HOLD RECOMMENDATION. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE MAKING A DECISION.
#swingtrading #indgn
#INDEGENE If there was any doubt yesterday about the breakout, it is all clear now. The breakout is here.
THIS IS NOT A BUY/SELL/HOLD RECOMMENDATION. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE MAKING A DECISION.
#swingtrading
#BulkDeals #Anandrathi
#ApolloPipes Promoter buys 1 %
#Clean Sundaram buys 0.7 %
#CreditAccess Promoter sell 2.2 %
#Indegene BPC Genesis EXITS 8.73 %
#Kpit MIT Sells 1 %
#OrientElec Nippon Adds 1.1 %
now holds 8.5 %
#Shadowfax Newquest sells 2.25 %
More deals NSE BSE Site
Block Deals
#Indegene
Brighton Park Capital exits Indegene for Rs 1,105 crore
Quant Mutual Fund buys 3.95% stake for Rs 500 crore, ICICI Prudential AMC picks up Rs 355 crore worth shares
#DStreetChatter | Market Consolidates In A Narrow Range
- Flows mixed with a positive bias
- #Defence stocks buzzing in trade
- #HAL #NavinFlourine #AUSmallFinancebank #IDFCFirstBank
#CapaciteInfra #Indegene #GlobusSpirits
@nimeshscnbc #CNBCTV18Market #CNBCTV18News
#Indegene sells brainwork to the world's biggest drug makers. Revenue ₹3,510 crore in FY26, up 23.6 percent. No debt. Net cash of ₹1,337 crore.
𝟭. 𝗧𝗵𝗲 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀
When a drug company launches a medicine, it needs a lot of work done. Marketing content for doctors. Medical and safety writing for regulators. Data and software to reach the right doctors. Indegene does that work for them, from India, using trained staff and its own software.
It is an asset light business. It owns almost no factories or machines. Property and plant is just 1.3 percent of assets. Money comes from people and software, not steel.
The customers are large and they stay. Indegene keeps most of its top 20 clients year after year. Active clients grew from 73 to 91 in FY26, then to 105 by June 2026. Clients paying more than 1 million dollars a year went from 41 to 53. North America is 71.5 percent of sales.
𝟮. 𝗧𝗵𝗲 𝘁𝗿𝗮𝗻𝘀𝗶𝘁𝗶𝗼𝗻 𝘂𝗻𝗱𝗲𝗿𝘄𝗮𝘆
Four engines drive a business like this. Sales growth. Profit margin. Cash. And return on capital, the profit earned for every rupee put into the business.
Three of the four are working. Sales are growing fast. Cash is real, the business turned ₹1.62 into cash from operations for every ₹1 of book profit in FY26. Return on capital, once you strip out the idle cash pile, is about 25.8 percent, which is high for a people business.
One engine is stuck. The profit margin. Operating margin, the share of sales kept as profit before interest, tax and depreciation, fell from 19.5 percent in FY24 to 17.6 percent in FY26. It was still only 16.4 percent in the June 2026 quarter. The company spent on senior hiring and AI, and the payoff has not landed yet.
𝟯. 𝗧𝗵𝗲 𝗴𝗿𝗼𝘄𝘁𝗵 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆
The market is huge and Indegene serves less than 1 percent of it. Room is not the limit.
The real prize is AI. Indegene is putting AI tools into live use. Medical writing that aims for faster regulatory filing. Content built in days instead of months. About 60 percent of revenue is now priced on output and results, not hours, so productivity gains can flow to profit.
Big deals won late in FY26 start showing up as revenue through FY27. One marketing programme above 10 million dollars a year. One biotech contract worth 20 million dollars over its life. If AI moves into the higher value, judgment heavy work faster than it cheapens the routine work, all four engines can fire together.
𝟰. 𝗧𝗵𝗲 𝘄𝗲𝗮𝗸𝗻𝗲𝘀𝘀𝗲𝘀
The reported profit hides the story. Group profit fell 1.4 percent in FY26 even though sales rose 23.6 percent. The India core actually grew profit 16.9 percent. The drag sat in newly bought foreign units.
The growth is flattered by buying, not just winning. Indegene bought three firms in FY26. Strip them out and organic growth slowed from 18.3 percent to 12 percent across two quarters.
The balance sheet got heavier. Those deals pushed goodwill and other soft assets, the extra paid to buy a company above its hard value, to 51.5 percent of net worth. And the assumptions used to test that goodwill for losses were softened in the same year it was booked.
𝟱. 𝗧𝗵𝗲 𝗿𝗶𝘀𝗸𝘀
The whole case leans on the margin recovering, and there is no dated plan for it, only management intent. If margin does not turn, profit stays soft and the business looks fully priced today.
Tax and legal claims add up to ₹153 crore, which is 38.2 percent of one year of profit. There is also a gap in the filings, where one report calls a tax demand final and another calls it still a draft.
The same AI that Indegene sells could cut billing across the whole industry. Rival firms showed the same slowdown in early 2026, so part of the softness is the market, not the company.
𝗪𝗵𝗼 𝗶𝘁 𝗰𝗼𝗺𝗽𝗲𝘁𝗲𝘀 𝘄𝗶𝘁𝗵
There is no exact twin on the market. The nearest listed names are eClerx and Sagility in business services, IKS Health on the hospital side, and Tata Elxsi in design with a health arm. Indegene sits in its own corner, drug company commercial work, and that is part of the edge. The moat is real but medium. Sticky work built into a client's daily systems. Deep health knowledge. A large database of doctors. Low cost delivery from India.
Last Seen Hashtags on Sotwe
teenageee
Seen from Turkey
anxiouspanda
Seen from Philippines
Unexpected(())*******filter:videos
Seen from United States
sex gay việt
Seen from Vietnam
classicpornstar
Seen from United States
skinsuit
Seen from France
ควยยาวลำใหญ่
Seen from Thailand
gayroblox
Seen from United States
mlp #porn
Seen from Malaysia
فطوم
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers